Zydus said the acquisition, through a subsidiary, will provide access to advanced biologics manufacturing capabilities and establish a key presence in the leading global biotechnology hub of California. Zydus...
Bristol Myers agrees up to $11.1 billion deal with BioNTech to shake up cancer immunotherapy
Bristol Myers Squibb (BMY.N) has agreed to pay up to $11.1 billion to partner with Germany’s BioNTech and develop the latter’s next-generation cancer immunotherapy, which could take on rival Merck &...
Sun Pharma’s Checkpoint buy: Why it’s a strategic fit in the new SPIL focus
India’s largest drug maker, Sun Pharmaceutical Industries, has completed its acquisition of US-based Checkpoint Therapeutics for approximately $355 million. This strategic move significantly strengthens Sun Pharma’s...
Sanofi finds M&A fix for its multiple itches
LONDON, June 2 (Reuters Breakingviews) – Sanofi is one European giant that’s still focused on the United States. The $123 billion French drugmaker will pay up to $9.5 billion, for Blueprint Medicines, a U.S. group...
Mapmygenome goes global, acquires Canada’s Microbiome Insights
The acquisition includes Microbiome Insights’ CAP-accredited Canadian laboratory and rich intellectual property, boosting Mapmygenome’s scientific prowess. Mapmygenome, a Hyderabad-headquartered AI-driven genomic and...
Swiss biotech firm Veraxa to list on Nasdaq in $1.64 billion SPAC deal
Swiss biotech investor Xlife Sciences AG said on Wednesday its portfolio company Veraxa Biotech AG would list on U.S. exchange Nasdaq in a $1.64 billion merger deal with a special-purpose acquisition vehicle, or SPAC...
KKR makes $1.2 billion offer for Sweden’s Biotage
Sweden’s Biotage said on Tuesday that KKR had made a cash offer for the Swedish biotechnology firm, valuing it at around 11.6 billion Swedish crowns ($1.22 billion). The offer price of 145 crowns per share...
Biotech firm Vyome Therapeutics to go public via reverse merger with Nasdaq-listed Reshape Lifesciences
Delhi-based biotech firm Vyome Therapeutics is set to go public in the US through a three-part transaction, including a reverse merger with California-based Reshape Lifesciences, according to statements issued by the...
Ajooni Biotech ties up with Avalon Bioenergy for sustainable moringa processing
Ajooni Biotech said that it has collaborated with Avalon Bioenergy, an Indian subsidiary of the US-based Avalon Energy Group, for sustainable processing of moringa in the country. This collaboration will see the setting...
KKR, Carlyle and EQT among five buyout funds in race for Healthium
Some of the biggest buyout funds KKR, Carlyle, EQT, Hillhouse and TA Associates are competing against each other to buy out Healthium Medtech, the largest homegrown surgical sutures manufacturer, also the largest...
Unitop shareholders drag Rossari Bio to arbitration
The shareholders of Unitop Chemicals started arbitration against promoters of Rossari Biotech, the company which had acquired Unitop in 2021. The Unitop shareholders have alleged that Rossari Biotech has breached the...
Alps Global to go public in US via $1.6 bln blank-check deal
Alps Global Holding Berhad on Wednesday agreed to go public in the U.S. through a merger with a blank-check company in a deal that valued the biotechnology company at $1.6 billion. The proceeds of the deal with special...
